Hält derzeit eine Position bei Tricida Inc
Position | Company | Period |
---|---|---|
Independent Director | Tricida Inc | 1. Januar 2014 - |
Independent Director | SI-BONE Inc | 1. April 2014 - 13. Juni 2019 |
Independent Director | Loxo Oncology Inc | 1. September 2013 - 22. Dezember 2017 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-24 | 2023-05-22 |
Prelude Therapeutics Inc
(PRLD)
|
K Kauf |
869.565
+9.4%
5,754.999.999 USD |
869.565 +9.4% | 5,75 | 4.999.999 USD | |
2022-11-25 | 2022-11-25 |
Tricida Inc
(TCDA)
|
V Verkauf |
3.629.226
-100.0%
0,22798.430 USD |
3.629.226 -100.0% | 0,22 | 798.430 USD | |
2022-11-25 | 2022-11-23 |
Tricida Inc
(TCDA)
|
V Verkauf |
5.617.300
-60.8%
0,211.179.633 USD |
5.617.300 -60.8% | 0,21 | 1.179.633 USD | |
2022-11-25 | 2022-11-22 |
Tricida Inc
(TCDA)
|
V Verkauf |
1.034.421
-10.1%
0,22227.573 USD |
1.034.421 -10.1% | 0,22 | 227.573 USD | |
2022-09-21 | 2022-09-19 |
Third Harmonic Bio Inc
(THRD)
|
K Kauf |
300.000
+5.5%
17,005.100.000 USD |
300.000 +5.5% | 17,00 | 5.100.000 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
197
-0.2%
33,926.682 USD |
197 -0.2% | 33,92 | 6.682 USD | |
2021-08-30 | 2021-08-30 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
6.500
-0.2%
33,92220.480 USD |
6.500 -0.2% | 33,92 | 220.480 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
209
-0.2%
33,947.093 USD |
209 -0.2% | 33,94 | 7.093 USD | |
2021-08-30 | 2021-08-27 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
6.884
-0.2%
33,94233.643 USD |
6.884 -0.2% | 33,94 | 233.643 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
126
-0.1%
34,524.350 USD |
126 -0.1% | 34,52 | 4.350 USD | |
2021-08-30 | 2021-08-26 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
4.157
-0.1%
34,52143.500 USD |
4.157 -0.1% | 34,52 | 143.500 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
208
-0.2%
34,347.143 USD |
208 -0.2% | 34,34 | 7.143 USD | |
2021-08-25 | 2021-08-25 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
6.874
-0.2%
34,34236.053 USD |
6.874 -0.2% | 34,34 | 236.053 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
119
-0.1%
34,074.054 USD |
119 -0.1% | 34,07 | 4.054 USD | |
2021-08-25 | 2021-08-24 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
3.920
-0.1%
34,07133.554 USD |
3.920 -0.1% | 34,07 | 133.554 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
209
-0.2%
34,067.119 USD |
209 -0.2% | 34,06 | 7.119 USD | |
2021-08-25 | 2021-08-23 |
Repare Therapeutics Inc
(RPTX)
|
GV Geplanter Verkauf |
6.885
-0.2%
34,06234.503 USD |
6.885 -0.2% | 34,06 | 234.503 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
K Kauf |
48.400
+70.2%
16,00774.400 USD |
48.400 +70.2% | 16,00 | 774.400 USD | |
2021-04-01 | 2021-03-30 |
Ikena Oncology Inc
(IKNA)
|
K Kauf |
375.000
+20.6%
16,006.000.000 USD |
375.000 +20.6% | 16,00 | 6.000.000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
K Kauf |
41.500
+inf%
18,00747.000 USD |
41.500 +inf% | 18,00 | 747.000 USD | |
2020-08-12 | 2020-08-10 |
Acutus Medical Inc
(AFIB)
|
K Kauf |
373.500
+inf%
18,006.723.000 USD |
373.500 +inf% | 18,00 | 6.723.000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
K Kauf |
99.200
+inf%
20,001.984.000 USD |
99.200 +inf% | 20,00 | 1.984.000 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
K Kauf |
675.000
+25.9%
20,0013.500.000 USD |
675.000 +25.9% | 20,00 | 13.500.000 USD | |
2020-03-16 | 2020-03-12 |
Imara Inc
(IMRA)
|
K Kauf |
937.500
+inf%
16,0015.000.000 USD |
937.500 +inf% | 16,00 | 15.000.000 USD | |
2019-04-05 | 2019-04-03 |
Tricida Inc
(TCDA)
|
K Kauf |
225.000
+2.1%
36,008.100.000 USD |
225.000 +2.1% | 36,00 | 8.100.000 USD |